Pharmaceutical Medicine

, Volume 27, Issue 6, pp 345–351

The Emergence of Regulatory Science in Pharmaceutical Medicine

Leading Article
  • 150 Downloads

Abstract

Against a backdrop of increasing costs and poor productivity, the concept of ‘regulatory science’ has sometimes been invoked in recent years in discussions regarding regulation of pharmaceuticals. There is not one generally accepted definition of regulatory science; however, there are several proposed definitions centered on a common theme: the ‘brand of science’ (knowledge, tools, concepts, etc.) that underpins and evolves regulatory decision making. This article provides a short review of the origins and features of regulatory science in addition to an exploration of its current and potential future role in pharmaceutical medicine. Moreover, the article discusses how regulatory science differs from traditional academic science and how it is related to the concept of regulatory affairs. It is concluded that the emerging field of regulatory science is likely to influence the future shaping and implementation of laws and regulations.

Copyright information

© Springer International Publishing Switzerland 2013

Authors and Affiliations

  • Torbjörn Callréus
    • 1
  • Christian K. Schneider
    • 1
    • 2
    • 3
  1. 1.Danish Health and Medicines AuthorityCopenhagenDenmark
  2. 2.Twincore Centre for Experimental and Clinical Infection ResearchHannoverGermany
  3. 3.Committee for Advanced Therapy Medicinal Products (CAT), European Medicines Agency (EMA)LondonUK

Personalised recommendations